Top Abstract Purchase Related
Home
>
Node
>
Subnode

Benefits of beta-blocker therapy for heart failure: weighing the evidence

Goldstein, S.

Archives of Internal Medicine 162(6): 641-648

2002

ISSN/ISBN: 0003-9926
PMID: 11911717
Document Number: 544786
Our understanding of factors contributing to the progression of heart failure has advanced dramatically over the past 2 decades. We have also gained considerable insight into the pharmacology of beta-adrenergic receptor blockers (beta-blockers). Based on this knowledge, we can now appreciate the potential of these drugs for the treatment of heart failure. Several beta-blockers have been shown to be clinically effective in the treatment of heart failure. Critical evaluation of the evidence from basic research studies, as well as clinical trials in patients with heart failure, helps to delineate the theoretical and clinical benefits of beta-blockers.

Document emailed within 1 workday
Secure & encrypted payments

Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Sheppard, R.J.; Racine, N.; Roof, A.; Ducharme, A.; Blanchet, M.; White, M. 2007: Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy Canadian Journal of Cardiology 23(14): 1135-1138
Furberg, C.D.; Byington, R.P. 1983: What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience Circulation 67(6 Part 2): I98-101
Gwathmey, J.K.; Kim, C.S.; Hajjar, R.J.; Khan, F.; DiSalvo, T.G.; Matsumori, A.; Bristow, M.R. 1999: Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol American Journal of Physiology 276(5): H1678-H1690
Böhm, M. 2003: Therapy of heart failure. which patients does the AT1 blocker help? MMW Fortschritte der Medizin 145(38): 8
Böhm, M. 2003: Therapy of heart failure. Which patients does the AT1 blocker help? MMW Fortschritte der Medizin 145(38): 8
DasGupta, P.; Broadhurst, P.; Lahiri, A. 1991: The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure Journal of Cardiovascular Pharmacology 18(Suppl 4): S12-S16
Löllgen, H.; Schmidt, A.; Upmeyer, H.J. 1986: Double-blind comparison of fixed combination preparations of a beta blocker and a diuretic and beta blocker, a diuretic and hydralazine in patients with coronary heart disease and arterial hypertension Medizinische Klinik 81(23): 745-750
Ivanenko, V.V.; Riazantseva, N.V.; Tarasov, D.L.; Lopatin, I.M. 2004: Effect of beta-Blocker Bisoprolol on Function of Hibernating Myocardium in Patients with Chronic Heart Failure of Ischemic Etiology Kardiologiia 44(7): 57-61
Zhuk, A.E.; Broun, L.M.; Mendelevich, L.A. 1986: Course of concomitant diseases in ischemic heart disease patients on long-term beta-blocker therapy Klinicheskaia Meditsina 64(2): 95-97
Ro, K.G.; Anderson, H.V. 1990: Thrombolytic therapy in acute MI. Weighing the risks and benefits Postgraduate Medicine 88(8): 79-80 83-6 89-90 Passim
Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7
Phillips, K.A.; Shlipak, M.G.; Coxson, P.; Heidenreich, P.A.; Hunink, M.G.; Goldman, P.A.; Williams, L.W.; Weinstein, M.C.; Goldman, L. 2000: Health and economic benefits of increased beta-blocker use following myocardial infarction JAMA 284(21): 2748-2754
Marks, R. 1995: Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure Lancet 345(8954): 930
Branzi, A.; Rapezzi, C. 1988: Beta-blockade therapy in heart failure. Rational bases of the interpretation of clinical data and clinical evidence in search of rational interpretation Giornale Italiano di Cardiologia 18(10): 843-846
Ong, H.T.; Ong, L.M.; Kow, F.P. 2012: Beta-blockers for heart failure: an evidence based review answering practical therapeutic questions Medical Journal of Malaysia 67(1): 7-11
Swedberg, K.; Skoglund, I. 2005: The use of beta blockaders in chronic heart failure shows how important the application of evidence based medicine really is Lakartidningen 102(8): 580
Pietruschka, W.D.; Scheuch, K.; Gruber, G.; Tomaschewskaja, L.I.; Reuschel, I. 1981: Heart rate and blood pressure under psychological and physical laboratory stress in young hypertensive patients following long-term therapy with the beta receptor blocker propranolol Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 36(6): 218-222
Kawanishi, D.T.; Reid, C.L.; Gonzales, A.; O'Rourke, R.A.; Rahimtoola, S.H. 1989: Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina Circulation 80(6 Suppl): Iv162-Iv170
Osterziel, K.J.; Dietz, R. 1997: Therapy of heart failure with beta-blockers? Zeitschrift für Kardiologie 86(1): 1-8